// App-Quantinova.ai

: Safety of Apixaban in Patients with CKD Stage V and ESRD with Venous Thromboembolism

Researchers

Presenter

  • Jahnavi Gollamudi

Principal Investigators

  • Sadeer Al-Kindi

  • Petra Martin

  • Lalitha V. Nayak

Medical Centers

  • Department of Medicine, Division of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

  • Division of Hematology-Oncology, Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Gastroenterology (GU)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

  • Hypertension

  • Cirrhosis

  • Solid malignancies

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Methadone hydrochloride

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved